Cannabis Shares to invest in

cannabis shares today

Get trading signals for Canabis shares

Will the price of Cannabis shares recover?

Canopy Growth Corp
Aphria Inc.
Cronos Group Inc.
Aurora Cannabis Inc.
Tilray Inc.

Cannabis Shares to invest in Libertex

What prospects do Canopy Growth stocks have?

Canopy Growth Corporation is one of the largest Canadian cannabis producers and has initially specialized in the manufacture of cannabis for medical purposes. Originally known as Tweed Marijuana Inc., the name was changed to Canopy Growth Corporation in September 2015.
It controls more than a third of the Canadian cannabis market and has seven cannabis manufacturing facilities in nine different countries around the world.

Canopy Growth Corp logo

Cannabis was legalized in Canada for medical purposes back in 2001, and in June 2018, Parliament passed a law permitting its use for personal use. Cannabis has been freely available in Canada since mid-October.
The shares of Canopy Growth Corporation, currently listed under the ticker symbol CGC on a number of exchanges, including the NYSE, have received a tremendous boost through the introduction of this law. After the sharp rise in October, when the price reached nearly $ 57, the stock fell to $ 33.5.

The shares of Canopy Growth Corporation were also strengthened by a $ 5 billion investment contract with American liquor maker Constellation Brands Inc., which also owns the beer brand Corona. US participation in Canopy Growth rises to 38%.
Despite the company’s relatively stable position, healthy market share and good outlook, we will not repeat this explosive growth in the near future.

Canopy Growth earnings facts and figures

Will the price of Aphria Inc. shares recover?

Aphria Inc. was founded in 2011 and is based in the Canadian province of Ontario. Among the founders is John Cervini, who left the tomato and pepper business in the greenhouse of his family to found Leamington – the company that would later become Aphria. Cervini entered the industry directly from traditional agriculture and therefore had no experience in the cultivation of cannabis. Today it is worth an estimated $ 145 million.

Aphria Inc.

Aphria Inc. received a license to manufacture and sell medicinal cannabis in 2014 and became a wholesaler in the Canadian market in 2015. More recently, the company announced plans to enter the US market (as well as several other markets throughout the Americas) and reiterated its intention to begin operations in Germany.

Unlike many competitors, cannabis is grown by Aphria Inc. under natural sunlight and not with artificial light.

The Company’s stock is listed on the NYSE under the ticker symbol APHA. Currently, the company’s market capitalization is $ 3.7 billion.

After peaking at $ 16.5 in mid-September, the stock dropped to $ 8.8 each. Following the trend across the industry, Aphria Inc.’s stock was massively boosted in June this year by the legalization of recreational cannabis in Canada.

Aphria Inc. earnings facts and figures

Will the shares of the Cronos Group reach their peak again?

Cronos Group Inc. is a relatively small cannabis producer. Its main activities include the production and distribution of cannabis and hemp oil, which are sold under the brand name Peace Naturals. The company has a license to sell medicinal cannabis and is active in the Australian and Israeli markets besides Canada.

Cronos Group predicts that its annual cannabis production in the first quarter of 2019 will exceed 47 tonnes (51 US tons). In view of the legalization of the sale of cannabis for recreational use in Canada, the Cronos Group has decided to open a chain of recreational pharmacies through a joint venture with the US company MedMen.

Cronos Group logo

In addition, the Cronos Group has entered into a 5-year exclusive distribution agreement with G. Pohl-Boskamp to supply more than 12,000 pharmacies in Germany.
Recently, there was talk of a possible step in Aurora Cannabis’s industrial footfall in acquiring the Cronos Group to increase its market share.

Cronos Group Inc. is listed on several exchanges including the NASDAQ under the ticker symbol CRON. The stock price is currently around $ 8.8 with a market capitalization of approximately $ 1.5 billion. Share prices across the sector rose sharply after Canada legalized cannabis for recreational use in June this year. The shares of the Cronos Group were no exception. On September 20, they reached their high of $ 13.75 a share, followed by a gradual downtrend that continues today.

Cronos Group earnings facts and figures

The Aurora Cannabis share has a positive outlook

Aurora Cannabis Inc. received a license to sell medical cannabis in 2014. Currently, the company has eight licensed manufacturing facilities in 18 countries, producing more than 500,000 kg of cannabis each year. Aurora Cannabis ranks second among companies in the industry in terms of market capitalization, the first being Canopy Growth Corp.

In 2018, the sale of cannabis for recreational purposes was legalized in Canada. The sale started on 17 October. The demand for this product has increased among the Canadian population and in some regions of Canada there is even a shortage of cannabis.

Aurora Cannabis Inc. currently intends to increase cannabis production capacity. Alberta is building a new facility in Alberta that can produce 100,000 kg of cannabis per year.

Aurora Cannabis Inc.

Since October 2018, the company’s stock is traded on the NYSE as ACB. The current price of Aurora Cannabis shares in New York is just over $ 6. The share price rose sharply shortly after the IPO, as interest in the sector had risen sharply, driven largely by the start of sales of recreational cannabis. At that time, the company’s stock was worth almost $ 12. Then the market turmoil calmed down; Aurora cannabis initially fell to $ 5.90 and then rose temporarily to 7- $ 8 and stabilized at just over $ 6.

The hype in the cannabis sector is probably over. However, a potential increase in production capacity could prove promising.

Aurora Cannabis earnings facts and figures

Is it possible to earn profits with Tilray Inc. Stocks?

Tilray Inc., a Canadian-based company that manufactures and sells medical cannabis to consumers and pharmaceutical distributors, has been trading on the NASDAQ since July 2018. About 76% of the company’s shares are held by Privateer Holdings Inc., Michael Blue and Christian Gros, founded by Brendan Kennedy.

After the Recruitment and Use of Cannabis for recreational use took effect in Canada in June, Tilray became the first company in the industry to go public. Later, the Drug Enforcement Administration officially approved Tilray Inc. to import medical cannabis for testing in California.

Tilray Inc. logo

In total, 109 million shares of Tilray are listed on the stock exchange. The company plans to increase Tilray’s market capitalization to $ 100 billion in the future. This value is now just under $ 10 billion.

In July, the stock price was $ 17, and today it’s just over $ 100. At some point, the price was over $ 200, although it was only $ 20 about a month after the IPO. Thereafter, the price rose in a similar way to the Bitcoin boom. The investors showed an increased interest in the industry, which at that time was not very active in the market. Later, the pace slowed as euphoria was over and a number of other companies active in the sector came to market. Thereafter, Tilray securities lost their exclusivity.

Currently, some large companies are showing interest in the cannabis market. Specifically, Microsoft has entered into a partnership agreement with Child Financial, a US-based startup that develops software for government agencies that control the production and sale of cannabis. Coca-Cola has also announced plans to produce drinks containing cannabis.

It is very likely that the opportunity to make a big profit from investing in Tilray has already passed. Nevertheless, the share price is rising steadily and should continue.

Tilray Inc. earnings facts and figures

Cannabis Shares to invest in

Cannabis Shares to invest in Libertex


Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 83% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.


  1. It is important to understand that investments in cannabis are not limited to breeders or retailers. There are numerous companies that provide ancillary services to the industry, as well as many derived games, such as pharmaceutical and biotech companies manufacturing cannabinoid-based drugs, as well as service providers outside the marijuana industry legalization on board

  2. Shares of Canadian medical marijuana producer and distributor Aurora Cannabis Inc. ( ACB ) reversed course on Tuesday, ending the day down some 4% after the company announced that its fiscal second-quarter revenue likely will ring in strong.

  3. I found your internet site from Google and also I need to say it was an excellent discover. Thanks!

  4. Hey there, You have done an incredible job. I will certainly digg it and personally recommend to my friends. I am confident they will be benefited from this site.

  5. Shares of most major Canadian cannabis producers are now being corrected after Hexo’s growth has risen to moderate to strong growth and earnings in the second quarter (up to $ 16.2 million) were better.

    As the company itself confirms, this success owes much of the strong increase in demand across the recreational cannabis sector. Just one day before, Hexo was another positive development that helped revive the market when the company acquired Newstrike Brands Ltd. announced – a company backed by former Canadian rock group The Tragically Hip – with an estimated value of $ 263 million ($ 198 million). Once the acquisition is completed, Hexo will gain additional production space on the order of 2 million square feet.
    Finally, the market received one last good news this week in the form of Aurora Cannabis (ACB) announcement that major investor Nelson Peltz had joined the company as a senior advisor.

    In summary, it is expected that this downward correction will continue in the medium to short term, as expected after such a sharp increase. Against this background, we can assume that the shares of the major Canadian manufacturers will continue their current development. Aurora Cannabis dropped to $ 8, Canopy Growh (CGC) to $ 45, Tilray (TLRY) to $ 72, Aphria to $ 12 and Cronos (CRON) to $ 20.

  6. Hey there! I’m at work browsing your blog from my new apple iphone!
    Just wanted to say I love reading your blog and look forward to all your posts! Keep up the fantastic work!

  7. It’s really a cool and useful piece of info. I’m glad that you just shared this helpful info with us.

    Please keep us up to date like this. Thank you for sharing.

  8. Thanks for sharing your info. I really appreciate your efforts and I am waiting for your further write ups thanks once again.

  9. I think the admin of this web site is really working hard for his site, since here every information is quality based data.

  10. Hello colleagues, how is the whole thing, and what you want to say concerning this piece of writing, in my view its in fact remarkable designed for me.

  11. It’s in fact very complex in this active life to listen news on Television, thus I only use internet for that reason, and get the most up-to-date information.

  12. Nice post. I learn something new and challenging on sites I stumbleupon on a daily basis. It will always be useful to read through articles from other authors and use a little something from other websites.

  13. With almost everything that appears to be building inside this particular subject matter, all your opinions happen to be fairly refreshing. Having said that, I am sorry, because I do not give credence to your whole theory, all be it exciting none the less. It seems to me that your commentary are generally not totally justified and in reality you are yourself not completely confident of the point. In any case I did take pleasure in reading through it.

  14. An interesting discussion is definitely worth comment.

    I do think that you should publish more on this subject,
    it may not be a taboo matter but usually folks don’t
    talk about these subjects. To the next! Best wishes!!

  15. I was checking continuously this blog and I am impressed! Extremely useful info specially the last part.

  16. To follow up on the up-date of this topic on your web-site and would wish to let you know just how much I loved the time you took to generate this handy post.

    In the post, you actually spoke of how to really handle this challenge with all comfort.
    It would be my own pleasure to collect some more strategies from your web page and come up to offer other individuals what I discovered from you.
    Thanks for your usual wonderful effort.

  17. This ensures that most personal details, in addition to economical info is always guarded for the highest and enables peace of mind.

  18. When most people think of marijuana stocks, they think of dividends. The legal marijuana industry is still very young and new companies in growing industries need money to expand. In addition, US investors in the marijuana market are currently focusing on a handful of Canadian companies that have the opportunity to list on US stock exchanges.

  19. Fundamentals are important – even for cannabis stocks
    What does the sector need to recover?

    Profits would be nice. Almost all major cannabis companies continue to lose a lot of money.

    George McBride, CEO of Hanway Associates, a London based consultancy specializing in cannabis research, said there are promising opportunities in the recreational and medical cannabis business. Companies just have to prove that they are not a straw fire.

    “The early cannabis promoters who listed their shares a few years ago did so at random and could quickly accumulate a lot of money astronomically, but they grew very fast and now sales did not meet investor expectations,” said McBride. who is also co-founder of the conference organization Cannabis Europa.

    In a sense, cannabis companies are suffering from the same problems as Uber, Lyft, Slack and many other ballyhooed startups that recently went public.

    “The sell-off of cannabis is part of a broader trend, with investors turning away from other unicorns because they want not only market share but also profits, and investors have not shown so much patience,” said McBride.

    Matt Markiewicz, Managing Director of Innovation Shares, who runs the Cannabis ETF, agreed that investors were too excited about the short-term outlook for the sector.

    “The exuberance in Canada for legalizing adult leisure consumption has been quite high, analysts’ sales and consumption expectations have been very optimistic and it just has not happened,” Markiewicz said.

  20. I’d need to check with you here. Which is not something I do! I quite like reading an article that can get people to think. Also, thanks for allowing me to comment!

  21. Wonderful web site. A lot of helpful info here. I am sending it to a few buddies ans additionally sharing in delicious.
    And of course, thank you on your sweat!

Leave a Reply

Your email address will not be published. Required fields are marked *